Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 19 studies | 28% ± 17% | |
| endothelial cell of vascular tree | 10 studies | 46% ± 19% | |
| oligodendrocyte | 9 studies | 25% ± 8% | |
| endothelial cell of lymphatic vessel | 8 studies | 29% ± 8% | |
| fibroblast | 7 studies | 25% ± 6% | |
| astrocyte | 5 studies | 21% ± 5% | |
| macrophage | 5 studies | 23% ± 7% | |
| pericyte | 5 studies | 20% ± 5% | |
| vein endothelial cell | 5 studies | 28% ± 13% | |
| oligodendrocyte precursor cell | 5 studies | 31% ± 9% | |
| type I pneumocyte | 4 studies | 24% ± 8% | |
| endothelial cell of artery | 4 studies | 24% ± 9% | |
| myofibroblast cell | 3 studies | 17% ± 1% | |
| epithelial cell | 3 studies | 31% ± 8% | |
| myeloid cell | 3 studies | 19% ± 1% | |
| retinal cone cell | 3 studies | 27% ± 6% | |
| basal cell | 3 studies | 42% ± 21% | |
| capillary endothelial cell | 3 studies | 27% ± 13% | |
| smooth muscle cell | 3 studies | 22% ± 2% | |
| GABAergic neuron | 3 studies | 46% ± 7% | |
| glutamatergic neuron | 3 studies | 49% ± 9% | |
| interneuron | 3 studies | 35% ± 17% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 37% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 5006.93 | 2642 / 2642 | 100% | 76.38 | 704 / 705 |
| skin | 100% | 3303.50 | 1806 / 1809 | 99% | 84.33 | 465 / 472 |
| kidney | 100% | 5419.85 | 89 / 89 | 96% | 53.81 | 864 / 901 |
| esophagus | 99% | 3141.00 | 1428 / 1445 | 96% | 20.33 | 175 / 183 |
| lung | 99% | 4284.63 | 574 / 578 | 95% | 21.48 | 1093 / 1155 |
| intestine | 100% | 3750.77 | 966 / 966 | 94% | 17.22 | 493 / 527 |
| stomach | 97% | 3121.50 | 349 / 359 | 95% | 18.07 | 272 / 286 |
| breast | 100% | 6116.67 | 459 / 459 | 92% | 33.48 | 1032 / 1118 |
| uterus | 99% | 2251.36 | 169 / 170 | 92% | 23.50 | 423 / 459 |
| pancreas | 89% | 1418.78 | 293 / 328 | 98% | 22.06 | 174 / 178 |
| thymus | 100% | 2866.34 | 650 / 653 | 87% | 26.55 | 529 / 605 |
| bladder | 100% | 3048.24 | 21 / 21 | 87% | 19.15 | 438 / 504 |
| liver | 100% | 6695.11 | 226 / 226 | 84% | 17.73 | 340 / 406 |
| prostate | 98% | 2591.42 | 239 / 245 | 79% | 10.81 | 395 / 502 |
| adrenal gland | 95% | 1756.87 | 246 / 258 | 80% | 15.54 | 185 / 230 |
| ovary | 62% | 724.27 | 112 / 180 | 46% | 6.51 | 198 / 430 |
| adipose | 100% | 4629.85 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 3240.99 | 1325 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 2085.99 | 793 / 803 | 0% | 0 | 0 / 0 |
| heart | 96% | 3562.54 | 824 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 18.88 | 43 / 45 |
| spleen | 94% | 1137.93 | 227 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 76% | 11.67 | 61 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 69% | 7.67 | 20 / 29 |
| peripheral blood | 14% | 147.77 | 128 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0048741 | Biological process | skeletal muscle fiber development |
| GO_0033173 | Biological process | calcineurin-NFAT signaling cascade |
| GO_0002931 | Biological process | response to ischemia |
| GO_0006979 | Biological process | response to oxidative stress |
| GO_0019722 | Biological process | calcium-mediated signaling |
| GO_0070885 | Biological process | negative regulation of calcineurin-NFAT signaling cascade |
| GO_0031987 | Biological process | locomotion involved in locomotory behavior |
| GO_0007614 | Biological process | short-term memory |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| GO_0008597 | Molecular function | calcium-dependent protein serine/threonine phosphatase regulator activity |
| GO_0003676 | Molecular function | nucleic acid binding |
| Gene name | RCAN1 |
| Protein name | Calcipressin-1 (Adapt78) (Down syndrome critical region protein 1) (Myocyte-enriched calcineurin-interacting protein 1) (MCIP1) (Regulator of calcineurin 1) Calcipressin-1 (Regulator of calcineurin 1) |
| Synonyms | ADAPT78 CSP1 DSCR1 DSC1 |
| Description | FUNCTION: Inhibits calcineurin-dependent transcriptional responses by binding to the catalytic domain of calcineurin A . Could play a role during central nervous system development (By similarity). . |
| Accessions | ENST00000399272.5 [P53805-3] ENST00000381135.7 ENST00000487990.5 [P53805-4] ENST00000482533.5 [P53805-4] E9PD55 ENST00000620920.4 [P53805-4] E9PDJ2 ENST00000492600.1 ENST00000381132.6 [P53805-2] V9GYW9 ENST00000481448.5 ENST00000443408.6 [P53805-4] P53805 ENST00000313806.9 [P53805-1] |